Consistent with the results obtained from the TCGA, IHC analysis showed higher OCLN expression in BLCA tumours than in adjacent tissues (Figure 1C), and OCLN expression was higher in patients with advanced tumours than in non‐advanced patients (Figure 1D). The gene discussed is OCLN; the disease is bladder transitional cell carcinoma.